Stocks / NASDAQ / Aimmune Therapeutics, Inc.

Aimmune Therapeutics, Inc.

Our Opinion

Aimmune tests some of its products on animals.

Company Description

Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers in the United States.

Website: http://www.aimmune.com